Quarterly report pursuant to Section 13 or 15(d)

Other Balance Sheet Items (Tables)

v3.25.0.1
Other Balance Sheet Items (Tables)
 3 Months Ended
Dec. 31, 2024
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
December 31, 2024 September 30, 2024
(in thousands)
Cash and cash equivalents $ 72,653  $ 183,123 
Restricted cash 50,217  52,640 
Cash, cash equivalents, and restricted cash $ 122,870  $ 235,763 
Schedule of Restrictions on Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
December 31, 2024 September 30, 2024
(in thousands)
Cash and cash equivalents $ 72,653  $ 183,123 
Restricted cash 50,217  52,640 
Cash, cash equivalents, and restricted cash $ 122,870  $ 235,763 
Schedule of Supplementary Cash Flow Information
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Three Months Ended
December 31, 2024 December 31, 2023
(in thousands)
Interest payments $ 17,559  $ 20,522 
Income tax payments/(refunds), net $ 12,418  $ (588)
Schedule of Details of Accounts Receivable
Table 10.3: Details of Accounts Receivable, Net
December 31, 2024 September 30, 2024
(in thousands)
Billed and billable receivables $ 672,288  $ 734,817 
Unbilled receivables 295,025  149,488 
Allowance for credit losses (4,663) (4,791)
Accounts receivable, net $ 962,650  $ 879,514